Seres Therapeutics Investors

21 investors on Angel Roster list Seres Therapeutics in their portfolio. Most are venture capital firms and entrepreneurship programs, the most common stage is Series A and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Seres Therapeutics can appear together.

Investors listed
21
With verified email
52%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 Seres Therapeutics investors

The most complete profiles first. Showing 21 of 21.

  • Alex GoldsmithVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Avak KahvejianVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Verified email available

  • Ewen CameronVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Molly GibsonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Nick PlugisVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Sabrina YangVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Sebastian TrousilVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Stephen BerensonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Torben Straight NissenVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Douglas ColeVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Ignacio MartinezVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 52 more

    Verified email available

  • Jim GilbertVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Eytan Weinstein

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Geoffrey von Maltzahn

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Harry Wilcox

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Contact details available

  • Jacob Rubens

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Nathan Stebbins

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Yiqun Bai, Ph.D.

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedEnterprise SoftwareEnergy

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • John Casey

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Jonathan Kabakoff

    Corporate Venture Capital · United States

    Health CareWomen FoundedChemicalLife Science

    Portfolio: Molecular Assemblies, Syros Pharmaceuticals, EpiBiome, Immunitas Therapeutics and 30 more

    Contact details available

  • Noubar Afeyan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

Frequently asked questions

How many Seres Therapeutics investors are on Angel Roster?

Angel Roster lists 21 Seres Therapeutics investors. 11 of them (52%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (20), Entrepreneurship Programs (9) and Corporate Venture Capital Firms (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Seres Therapeutics investors invest in?

Among those that list a stage, the most common are Series A (14) and Series B (1).

Where are Seres Therapeutics investors based?

Most are based in the United States (21).

Which companies have Seres Therapeutics investors backed?

The most-backed portfolio companies among them are Syros Pharmaceuticals (21), Editas Medicine (21), Codiak Biosciences (21), Visterra (21) and Incredible Foods (20).

How do I contact Seres Therapeutics investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.